Research Investigator SR - School of Medicine

Pennsylvania (US)
17 Aug 2018
End of advertisement period
17 Oct 2018
Contract Type
Fixed Term

The University of Pennsylvania, the largest private employer in Philadelphia, is a world-renowned leader in education, research, and innovation. This historic, Ivy League school consistently ranks among the top 10 universities in the annual U.S. News & World Report survey. Penn has 12 highly-regarded schools that provide opportunities for undergraduate, graduate and continuing education, all influenced by Penn’s distinctive interdisciplinary approach to scholarship and learning.

Penn offers a unique working environment within the city of Philadelphia. The University is situated on a beautiful urban campus, with easy access to a range of educational, cultural, and recreational activities. With its historical significance and landmarks, lively cultural offerings, and wide variety of atmospheres, Philadelphia is the perfect place to call home for work and play.

The University offers a competitive benefits package that includes excellent healthcare and tuition benefits for employees and their families, generous retirement benefits, a wide variety of professional development opportunities, supportive work and family benefits, a wealth of health and wellness programs and resources, and much more.

The Perelman School of Medicine at the University of Pennsylvania is the oldest and one of the finest medical schools in the United States. Penn is rich in tradition and heritage and at the same time consistently at the forefront of new developments and innovations in medical education and research. Since its founding in 1765 the School has been a strong presence in the community and prides itself on educating the leaders of tomorrow in patient care, biomedical research, and medical education.

Candidate needed to perform research on multiple projects aimed at better understand cancer metabolic reprogramming that is potentially therapeutically exploitable. In particular, the candidate will studying cancer metabolism using circadian metabolomics of Myc oncogene induced cell systems, as well as, different mammalian cell lines such as osteosarcoma, and neuroblastoma cells. The candidate will also perform metabolomics analyses on triple negative breast cancer and human lung cancer cell lines along with their sub-clones which lack GAC isoforms. The individual should also be willing to work in a highly collaborative environment to support ongoing projects in the laboratory, train lab members, independently design/coordinate/execute research studies in consultation with the PI, and help in preparing manuscripts, presentations, and grant applications.

Ph. D. or equivalent doctoral degree and at least 5 years post-doctoral experience in circadian metabolomics or related field are required. The preferred candidate will have at least 5 years of experience working with high resolution mass spectrometers, maintenance and troubleshooting as well as outstanding oral and written communication skills. The highly preferred candidate will have a proven record of first-author publications, management and technical skills in leading a small research group, and the ability to regularly review and maintain research records for a research group.

Penn adheres to a policy that prohibits discrimination on the basis of race, color, sex, sexual orientation, gender identity, religion, creed, national or ethnic origin, citizenship status, age, disability, veteran status, or any other legally protected class.